17 alpha-hydroxylase deficiency historical perspective: Difference between revisions
| Line 9: | Line 9: | ||
==Landmark Events in the Development of Treatment Strategies== | ==Landmark Events in the Development of Treatment Strategies== | ||
* In 1965, the | * In 1965, the diagnosis of congenital adrenal hyperplasia was established by measuring the levels of adrenal hormones in the amniotic fluid. | ||
* In 1982, International Newborn Screening Meeting recommended new born screening for congenital adrenal hyperplasia. | * In 1982, International Newborn Screening Meeting recommended new born screening for congenital adrenal hyperplasia. | ||
* In 1989, Texas included congenital adrenal hyperplasia in its Newborn Screening Program. | * In 1989, Texas included congenital adrenal hyperplasia in its Newborn Screening Program. | ||
Revision as of 19:31, 7 February 2016
|
Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
17 alpha-hydroxylase deficiency historical perspective On the Web |
|
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency historical perspective |
|
FDA on 17 alpha-hydroxylase deficiency historical perspective |
|
CDC on 17 alpha-hydroxylase deficiency historical perspective |
|
17 alpha-hydroxylase deficiency historical perspective in the news |
|
Blogs on 17 alpha-hydroxylase deficiency historical perspective |
|
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency was first reported by Dr. Edward G. Biglieri, an American endocrinologist, in 1963-1966 following publication of a case report.[1]
Discovery
- Congenital adrenal hyperplasia was first discovered by Dr. Luigi DeCrecchio, an Italian anatomist, in 1865 following a case report of a female patient with enlarged adrenal glands, male external genitalia, absence of testicles, and female internal reproductive organs.[2]
- Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency was first reported by Dr. Edward G. Biglieri, an American endocrinologist, in 1963-1966 following publication of a case report.[1]
Landmark Events in the Development of Treatment Strategies
- In 1965, the diagnosis of congenital adrenal hyperplasia was established by measuring the levels of adrenal hormones in the amniotic fluid.
- In 1982, International Newborn Screening Meeting recommended new born screening for congenital adrenal hyperplasia.
- In 1989, Texas included congenital adrenal hyperplasia in its Newborn Screening Program.
References
- ↑ 1.0 1.1 Biglieri, E G; Herron, M A; Brust, N (1966). "17-hydroxylation deficiency in man". Journal of Clinical Investigation. 45 (12): 1946–1954. doi:10.1172/JCI105499. ISSN 0021-9738.
- ↑ History of Congenital Adrenal Hyperplasia. Texas department of state health services (2016). http://www.dshs.state.tx.us/newborn/histor~1.shtm Accessed on February 4, 2016